242 related articles for article (PubMed ID: 11483392)
21. [Lafora's disease (EPM2)].
Genton P
Rev Neurol (Paris); 2007 Jan; 163(1):47-53. PubMed ID: 17304172
[TBL] [Abstract][Full Text] [Related]
22. Early-onset Lafora body disease.
Turnbull J; Girard JM; Lohi H; Chan EM; Wang P; Tiberia E; Omer S; Ahmed M; Bennett C; Chakrabarty A; Tyagi A; Liu Y; Pencea N; Zhao X; Scherer SW; Ackerley CA; Minassian BA
Brain; 2012 Sep; 135(Pt 9):2684-98. PubMed ID: 22961547
[TBL] [Abstract][Full Text] [Related]
23. Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene.
Ganesh S; Shoda K; Amano K; Uchiyama A; Kumada S; Moriyama N; Hirose S; Yamakawa K
Mol Cell Probes; 2001 Oct; 15(5):281-9. PubMed ID: 11735300
[TBL] [Abstract][Full Text] [Related]
24. Unusual presentation of Lafora's disease.
Al Otaibi SF; Minassian BA; Ackerley CA; Logan WJ; Weiss S
J Child Neurol; 2003 Jul; 18(7):499-501. PubMed ID: 12940657
[TBL] [Abstract][Full Text] [Related]
25. [Myoclonic epilepsy of Lafora: a case report].
Rudenskaia GE; Zakharova EIu; Karpin SL; Uchaev DA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):11-6. PubMed ID: 20873469
[TBL] [Abstract][Full Text] [Related]
26. Accumulation of Laforin and Other Related Proteins in Canine Lafora Disease With EPM2B Repeat Expansion.
Chambers JK; Thongtharb A; Shiga T; Azakami D; Saito M; Sato M; Morozumi M; Nakayama H; Uchida K
Vet Pathol; 2018 Jul; 55(4):543-551. PubMed ID: 29444631
[TBL] [Abstract][Full Text] [Related]
27. [Molecular genetics of epilepsy].
Yamakawa K
Rinsho Shinkeigaku; 2004 Nov; 44(11):858-60. PubMed ID: 15651314
[TBL] [Abstract][Full Text] [Related]
28. [Lafora's disease and movement disorders: report of 2 cases].
de Quadros A; Sá DS; Kowacs PA; Teive HA; Werneck LC
Arq Neuropsiquiatr; 2000 Sep; 58(3A):720-3. PubMed ID: 10973115
[TBL] [Abstract][Full Text] [Related]
29. Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice.
Ganesh S; Delgado-Escueta AV; Sakamoto T; Avila MR; Machado-Salas J; Hoshii Y; Akagi T; Gomi H; Suzuki T; Amano K; Agarwala KL; Hasegawa Y; Bai DS; Ishihara T; Hashikawa T; Itohara S; Cornford EM; Niki H; Yamakawa K
Hum Mol Genet; 2002 May; 11(11):1251-62. PubMed ID: 12019206
[TBL] [Abstract][Full Text] [Related]
30. Polyglucosan storage disease in a dog resembling Lafora's disease.
Schoeman T; Williams J; van Wilpe E
J Vet Intern Med; 2002; 16(2):201-7. PubMed ID: 11899039
[No Abstract] [Full Text] [Related]
31. Lafora Disease: A Review of Molecular Mechanisms and Pathology.
Verhalen B; Arnold S; Minassian BA
Neuropediatrics; 2018 Dec; 49(6):357-362. PubMed ID: 30336494
[TBL] [Abstract][Full Text] [Related]
32. Lafora's-like disease in a fennec fox (Vulpes zerda).
Honnold SP; Schulman FY; Bauman K; Nelson K
J Zoo Wildl Med; 2010 Sep; 41(3):530-4. PubMed ID: 20945656
[TBL] [Abstract][Full Text] [Related]
33. Lafora's disease. The role of skin biopsy.
Newton GA; Sanchez RL; Swedo J; Smith EB
Arch Dermatol; 1987 Dec; 123(12):1667-9. PubMed ID: 2825605
[TBL] [Abstract][Full Text] [Related]
34. Mutations in NHLRC1 cause progressive myoclonus epilepsy.
Chan EM; Young EJ; Ianzano L; Munteanu I; Zhao X; Christopoulos CC; Avanzini G; Elia M; Ackerley CA; Jovic NJ; Bohlega S; Andermann E; Rouleau GA; Delgado-Escueta AV; Minassian BA; Scherer SW
Nat Genet; 2003 Oct; 35(2):125-7. PubMed ID: 12958597
[TBL] [Abstract][Full Text] [Related]
35. [Lafora disease complicating myoclonus epilepsy. Report of 3 cases].
Testa G; Armani M; Giaretta D; Angelini C
Riv Neurol; 1980; 50(5):338-49. PubMed ID: 6781057
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional profiling of a mouse model for Lafora disease reveals dysregulation of genes involved in the expression and modification of proteins.
Ganesh S; Tsurutani N; Amano K; Mittal S; Uchikawa C; Delgado-Escueta AV; Yamakawa K
Neurosci Lett; 2005 Oct; 387(2):62-7. PubMed ID: 16084644
[TBL] [Abstract][Full Text] [Related]
37. [Lafora's progressive myoclonus epilepsy and diagnosed cases in Costa Rica].
Solís V
Rev Biol Trop; 2004 Sep; 52(3):571-84. PubMed ID: 17361551
[TBL] [Abstract][Full Text] [Related]
38. Late-onset Lafora's disease with typical intraneuronal inclusions.
Kaufman MA; Dwork AJ; Willson NJ; John S; Liu JD
Neurology; 1993 Jun; 43(6):1246-8. PubMed ID: 8170576
[TBL] [Abstract][Full Text] [Related]
39. Regional and developmental expression of Epm2a gene and its evolutionary conservation.
Ganesh S; Agarwala KL; Amano K; Suzuki T; Delgado-Escueta AV; Yamakawa K
Biochem Biophys Res Commun; 2001 May; 283(5):1046-53. PubMed ID: 11355878
[TBL] [Abstract][Full Text] [Related]
40. Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes.
Ganesh S; Agarwala KL; Ueda K; Akagi T; Shoda K; Usui T; Hashikawa T; Osada H; Delgado-Escueta AV; Yamakawa K
Hum Mol Genet; 2000 Sep; 9(15):2251-61. PubMed ID: 11001928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
